DexCom Stock Down Despite Earnings Estimates Showing Strong Growth
-
DexCom (DXCM) stock fell slightly despite gains in the broader market. The company is set to report earnings on October 26.
-
Analyst estimates project strong growth, with EPS up 41% and revenue up 22% year-over-year.
-
DXCM stock has underperformed recently, down 20% over the past month.
-
The medical instruments industry overall ranks in the top 40% of Zacks industries, suggesting potential for gains.
-
DexCom has a forward P/E ratio of 67.61, well above the industry average of 25.02, indicating it trades at a premium.